EP 3976001 A4 20230426 - TABLET FORMULATIONS OF APREMILAST
Title (en)
TABLET FORMULATIONS OF APREMILAST
Title (de)
TABLETTENFORMULIERUNGEN VON APREMILAST
Title (fr)
FORMULATIONS DE COMPRIMÉS D'APRÉMILAST
Publication
Application
Priority
- TR 201908440 A 20190531
- TR 2020050318 W 20200415
Abstract (en)
[origin: WO2020242414A1] The present invention relates to tablet formulations of apremilast or a pharmaceutically acceptable salt, solvate or polymorph thereof used for the treating or preventing of psoriatic arthritis and/or psoriasis. It further relates to processes of preparation of the formulations and the method of use for these formulations.
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/4035 (2006.01); A61P 19/02 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 31/4035 (2013.01); A61P 19/02 (2017.12); A61K 9/2866 (2013.01)
Citation (search report)
- [I] WO 2017083348 A1 20170518 - CELGENE CORP [US]
- See references of WO 2020242414A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020242414 A1 20201203; EP 3976001 A1 20220406; EP 3976001 A4 20230426; TR 201908440 A2 20201221
DOCDB simple family (application)
TR 2020050318 W 20200415; EP 20813638 A 20200415; TR 201908440 A 20190531